ARCHIVES

Samuel Broder Plans To Leave Celera.

This article is from The Cancer Letter archive.

Vol. 36 No. 32 | September 10, 2010

Download PDF Visit The Full Archive

Related Articles

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

FDA Designates Zometa For Priority Review.

November 30, 2001

NCI Cooperative Group Clinical Trials Approved

September 24, 2010

Patient’s Husband To Fund Fellowship At Dana-Farber

September 8, 1995

In Brief: Arlan Gottlieb, CALGB Leader, Dead At 55; NCI’s John Cooper Undergoes Heart Transplant

July 7, 1989

In Brief: Mathews Could Help In Fighting OMB Obstruction Of Cancer Program; Easily Wins Senate Approval

August 1, 1975